• AAPL 192.32
  • TSLA 239.37
  • AMZN 144.52
  • BTC-USD 43909.543
  • ETH-USD 2262.0955
  • EURUSD 1.078
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. PDSB.US

PDS Biotechnology Corp (PDSB NASDAQ) stock market data APIs

$5.37 0.21(4.1%) as of December 6, 2023

PDS Biotechnology Corp Financial Data Overview

5.16
5.37
-
5.41
5.13
3.8-13.65
163 M
31 108 K
0
-0.35
0
1.729
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PDSB',
Type: 'Common Stock',
Name: 'PDS Biotechnology Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG004NCDK82',
ISIN: NULL,
CUSIP: NULL,
CIK: '1472091',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2015-10-01',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
GicSector: 'Health Care',
GicGroup: 'Pharmaceuticals, Biotechnology & Life Sciences',
GicIndustry: 'Biotechnology',
GicSubIndustry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

PDS Biotechnology Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -51 405 128
  • Earnings Per Share -1.71
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $49.99 See full price
Get sample
of Fundamental API Data

Get PDS Biotechnology Corp Earnings via APIs

  • Latest Release 2023-11-14
  • EPS/Forecast -0.45

Get PDS Biotechnology Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get PDS Biotechnology Corp latest news via APIs

PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer

PRINCETON, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing a growing ...
  • DIRECTORS AND OFFICERS
  • NASDAQ:PDSB
  • PDS BIOTECHNOLOGY CORPORATION

PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update

Announced 75% of ICI-naive patients alive at 36 months in the NCI-led triple Phase 2 combination trial for advanced HPV16-positive cancer patients; published median overall survival of 7-11 months wit...
  • EARNINGS RELEASES AND OPERATING RESULTS
  • NASDAQ:PDSB
  • PDS BIOTECHNOLOGY CORPORATION
Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com